Cargando…
A genetically stable Zika virus vaccine candidate protects mice against virus infection and vertical transmission
Although live attenuated vaccines (LAVs) have been effective in the control of flavivirus infections, to date they have been excluded from Zika virus (ZIKV) vaccine trials due to safety concerns. We have previously reported two ZIKV mutants, each of which has a single substitution in either envelope...
Autores principales: | Adam, Awadalkareem, Fontes-Garfias, Camila R., Sarathy, Vanessa V., Liu, Yang, Luo, Huanle, Davis, Emily, Li, Wenqian, Muruato, Antonio E., Wang, Binbin, Ahatov, Renat, Mahmoud, Yoseph, Shan, Chao, Osman, Samantha R., Widen, Steven G., Barrett, Alan D. T., Shi, Pei-Yong, Wang, Tian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889622/ https://www.ncbi.nlm.nih.gov/pubmed/33597526 http://dx.doi.org/10.1038/s41541-021-00288-6 |
Ejemplares similares
-
An attenuated Zika virus NS4B protein mutant is a potent inducer of antiviral immune responses
por: Li, Guangyu, et al.
Publicado: (2019) -
Maternal vaccination and protective immunity against Zika virus vertical transmission
por: Shan, Chao, et al.
Publicado: (2019) -
Rational Development of Live-Attenuated Zika Virus Vaccines
por: Adam, Awadalkareem, et al.
Publicado: (2023) -
Blocking Zika virus vertical transmission
por: Mesci, Pinar, et al.
Publicado: (2018) -
Attenuation of Zika Virus by Passage in Human HeLa Cells
por: Li, Li, et al.
Publicado: (2019)